Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
about
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphomaFascin expression in CD30-positive cutaneous lymphoproliferative disordersCD30+ Lymphoproliferative Disorders of the Skin.Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study.Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivoClassification of lymphoid neoplasms: the microscope as a tool for disease discovery.The current status of lymphoma classification.Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma.Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsiesPeripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.A case of lymphomatoid papulosis occurred simultaneously with Ki-1-positive anaplastic large cell lymphoma.Primary cutaneous CD 30+ anaplastic large cell lymphomaFrequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid PapulosisNeed for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.Symmetrical lymphomatoid papulosis masquerading as pyoderma chancriformis of the eyelids.CD30+ neoplasms of the skin.Coexistence of CD30-positive anaplastic large cell lymphoma and mycosis fungoides.A case of mycosis fungoides after CD30 positive anaplastic large cell lymphoma.CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.Brentuximab vedotin in CD30(+) primary cutaneous T-cell lymphomas: a review and analysis of existing data.Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review.Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.Ki-1 skin lymphoproliferative disorders: management with radiation therapy.Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.Lymphomatoid papulosis in children: a series of 25 cases.Regulation of CD30 antigen expression and its potential significance for human disease.CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.Stage IV CD30+ anaplastic large cell lymphoma: response to acitretin and interferon-alpha.Human herpesvirus type 8 and epstein-barr virus-associated cutaneous lymphoma taking anaplastic large cell morphology in a man with HIV infection.Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.CD30+ lymphoproliferative disorder with spindle-cell morphology.Lymphomatoid papulosis in children: experience of five cases and the treatment efficacy of methotrexate.[Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].A case of Ki-1 positive anaplastic large cell lymphoma transformed from mycosis fungoides.
P2860
Q27000343-DD5D5709-770D-444F-916E-44422BB02B66Q28213139-6CEC61A7-9157-4810-94CB-978CA9052860Q30235097-4350D78A-C018-42CA-BF16-7379D25918C3Q30444998-A3842A13-259E-4A49-984F-70295F8330E4Q31090571-E5F65891-4EFB-4BB8-971B-F2FDEC968E4CQ33386690-636721B1-D1C9-45AE-A638-3E8A2AE86C8CQ33940248-E4AD4BBF-954B-417A-A514-6081374F9480Q34194246-BCF508CA-0F37-4584-B74B-9BD1B87344C9Q34266303-08060EA9-78AA-4A12-A99D-68DE1F4F92E9Q35065024-FDBE0517-5C0B-4B93-926D-4E24DA57991FQ35104376-FC807FD7-E00E-4D08-9A36-DED00078D769Q35754143-259011DB-E9A6-4AA6-9909-855CF5C61604Q35773778-68E92C9D-E64E-4BC0-A266-B9C8B57BF38BQ35938576-15BB22CE-FA05-4F2F-A489-05E7CECC8904Q36260002-39A90B32-A943-48EC-A758-1673B4CFB0F8Q36452258-E4BCD909-C325-44C2-9A3D-8D07AF6C8B8BQ36771224-A76A4C2B-619D-4197-A03D-639FBD01ECE6Q37311667-9D615587-A543-4A65-B3E0-B8BBB1F21A18Q37919372-7FEE701E-F0DB-4390-9FD7-B5D07A1CBF68Q38522575-6D5EF8B1-0CE9-4E35-B034-6A8339D23D80Q38526040-B81BBA0D-6FCC-4C1B-BBCA-DB234284C8F2Q38526421-BBFEB975-3DFE-493E-B82B-7C0815C48A45Q38649847-FDFEBB9B-7227-4767-B96A-77083ED66726Q38813983-0104B583-B5AE-4D97-9C51-DAF24BF00225Q38823698-E9F1D60B-F438-4807-8F50-3904D7BAF046Q40990296-3792CC80-C285-44F9-85BB-572C2D679400Q41421600-5969B78D-7D4D-4F7C-9D93-135E514F5EAFQ41685506-891A1E07-C4D3-460D-A788-ED00DB65B86AQ42049625-78BB722F-1B07-43A6-9A09-2AD68E705F8DQ42223414-A1AB0566-27C9-414B-B3BB-499E2F42C43BQ42775424-26541ECC-DBAB-48F2-8B50-D9656201F7FCQ43674472-C0A207D4-9612-4BA4-ADF8-FDB1CB5715C3Q43969661-5B7E381A-131A-45E3-80B8-4568C25DC701Q44066490-F93F6F5C-7DE6-4714-B457-C102170974F6Q45748234-5AAC363E-95EB-4DDA-B336-EF0129FE8993Q51614434-DA320EA9-8373-4976-852F-64E4C55A2381Q51631387-324871FE-C0E1-4134-9D23-80F009307E06Q52730451-D65E765B-CEF8-4CF3-91B1-D61B7751D5B3Q52888610-2CE6BD3A-29D3-44BC-B6B3-B1A7AB5E0A01Q53451429-18FA548B-8ED8-49AE-A5C9-1DCA5C9D3A8D
P2860
Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Spectrum of primary cutaneous ...... for management and treatment.
@en
type
label
Spectrum of primary cutaneous ...... for management and treatment.
@en
prefLabel
Spectrum of primary cutaneous ...... for management and treatment.
@en
P1476
Spectrum of primary cutaneous ...... for management and treatment.
@en
P2093
Beljaards RC
Willemze R
P304
P356
10.1016/0190-9622(93)70140-O
P407
P577
1993-06-01T00:00:00Z